Harvard Bioscience Market Cap 2010-2025 | HBIO
Harvard Bioscience market cap history and chart from 2010 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Harvard Bioscience market cap as of July 24, 2025 is $0.03B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.025B | $0.094B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $6.129B | 17.21 |
| Kewaunee Scientific (KEQU) | United States | $0.170B | 10.70 |
| International Isotopes (INIS) | United States | $0.056B | 0.00 |